Rxivist logo

Discovery and biosynthesis of the antibiotic bicyclomycin in distant bacterial classes

By Natalia M. Vior, Rodney Lacret, Govind Chandra, Siobhán Dorai-Raj, Martin Trick, Andrew W. Truman

Posted 21 Dec 2017
bioRxiv DOI: 10.1101/236828 (published DOI: 10.1128/aem.02828-17)

Bicyclomycin (BCM) is a clinically promising antibiotic that is biosynthesised by Streptomyces cinnamoneus DSM 41675. BCM is structurally characterized by a core cyclo(L-Ile-L-Leu) 2,5-diketopiperazine (DKP) that is extensively oxidized. Here, we identify the BCM biosynthetic gene cluster, which shows that the core of BCM is biosynthesised by a cyclodipeptide synthase and the oxidative modifications are introduced by five 2-oxoglutarate-dependent dioxygenases and one cytochrome P450 monooxygenase. The discovery of the gene cluster enabled the identification of BCM pathways encoded in the genomes of hundreds of Pseudomonas aeruginosa isolates distributed globally, and heterologous expression of the pathway from P. aeruginosa SCV20265 demonstrated that the product is chemically identical to BCM produced by S. cinnamoneus. Overall, putative BCM gene clusters have been found in at least seven genera spanning Actinobacteria and Proteobacteria (Alpha-, Beta- and Gamma-). This represents a rare example of horizontal gene transfer of an intact biosynthetic gene cluster across such distantly related bacteria, and we show that these gene clusters are almost always associated with mobile genetic elements.

Download data

  • Downloaded 410 times
  • Download rankings, all-time:
    • Site-wide: 47,305 out of 103,871
    • In microbiology: 3,504 out of 9,238
  • Year to date:
    • Site-wide: 76,114 out of 103,871
  • Since beginning of last month:
    • Site-wide: 64,919 out of 103,871

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)